## Molecular Mechanism of Crystal-Induced Acute Inflammation (Gout) ### Clinical Diagnosis This patient has **acute gouty arthritis** (gout), confirmed by: - Needle-shaped, negatively birefringent crystals = **monosodium urate (MSU) crystals** - Acute inflammatory response with high neutrophil count - Sterile synovial fluid (negative cultures) - Elevated inflammatory markers ### The NLRP3 Inflammasome Pathway **High-Yield:** The NLRP3 inflammasome is the central molecular hub for crystal-induced inflammation in gout. This is a **high-yield topic for NEET PG pathology**. ### Step-by-Step Mechanism ```mermaid flowchart TD A[MSU crystals phagocytosed by macrophages/monocytes]:::outcome --> B[Phagolysosomal rupture]:::action B --> C[Release of cathepsin B into cytoplasm]:::action C --> D[NLRP3 inflammasome assembly]:::action D --> E[Caspase-1 activation]:::action E --> F[Cleavage of pro-IL-1β and pro-IL-18]:::action F --> G[Release of mature IL-1β and IL-18]:::outcome G --> H[Neutrophil recruitment and activation]:::action H --> I[Acute inflammatory response]:::outcome ``` ### Key Molecular Events **Key Point:** The NLRP3 inflammasome is a multiprotein complex consisting of: 1. **NLRP3** (nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3) 2. **ASC** (apoptosis-associated speck-like protein containing a CARD) 3. **Pro-caspase-1** ### Detailed Pathway | Step | Event | Mechanism | |------|-------|----------| | 1 | Crystal phagocytosis | MSU crystals are internalized by resident macrophages | | 2 | Phagolysosomal rupture | Crystal-induced damage to phagolysosomal membrane | | 3 | Cathepsin B release | Lysosomal protease released into cytoplasm | | 4 | NLRP3 activation | Cathepsin B triggers NLRP3 inflammasome assembly | | 5 | Caspase-1 activation | Pro-caspase-1 is cleaved to active caspase-1 | | 6 | Cytokine maturation | Pro-IL-1β → IL-1β; Pro-IL-18 → IL-18 | | 7 | Cytokine secretion | IL-1β and IL-18 released into joint space | | 8 | Neutrophil recruitment | IL-1β acts as potent chemoattractant | | 9 | Acute inflammation | Neutrophil-mediated inflammation and pain | ### Why IL-1β is Central **Clinical Pearl:** IL-1β is the **master cytokine** in gout: - Potent neutrophil chemoattractant - Induces COX-2 and prostaglandin E2 (PGE2) production - Increases vascular permeability - Induces pain via TRPV1 activation - Explains why **colchicine and NSAIDs work** — they block IL-1β signaling and neutrophil recruitment ### Why Colchicine Works **High-Yield:** Colchicine inhibits: 1. Microtubule polymerization 2. NLRP3 inflammasome assembly 3. IL-1β secretion This is why colchicine is effective in acute gout — it blocks the inflammasome before IL-1β is released. ### Why IL-1β Inhibitors Work Monoclonal antibodies against IL-1β (canakinumab) and IL-1 receptor antagonists (anakinra) are highly effective in acute gout because they block the final common pathway of inflammation. ### Mnemonic for NLRP3 Activation **Mnemonic: CRACK** (Crystal Recognition And Cathepsin-mediated Kinase activation) - **C**rystal phagocytosis - **R**upture of phagolysosome - **A**ctivation of inflammasome - **C**aspase-1 cleavage - **K**inase-independent IL-1β release
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.